MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/760/0.01/20.12.24 Share Price

Warrant

DE000MB3T792

Delayed Börse Stuttgart 09:28:30 25/06/2024 pm IST
0.052 EUR -1.89% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/760/0.01/20.12.24
Current month-11.86%
1 month-34.18%
Date Price Change
25/24/25 0.052 -1.89%
24/24/24 0.053 +43.24%
21/24/21 0.037 0.00%
20/24/20 0.037 -11.90%
19/24/19 0.042 -22.22%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 09:28 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MB3T79
ISINDE000MB3T792
Date issued 17/02/2023
Strike 760 $
Maturity 20/12/2024 (178 Days)
Parity 100 : 1
Emission price 0.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.48
Lowest since issue 0.035
Spread 0.034
Spread %39.53%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
491.1 USD
Average target price
564.1 USD
Spread / Average Target
+14.88%
Consensus